Difenac

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Difenac

What is Difenac? (A Foundational Overview)

Property Description
Active ingredient Diclofenac (Typically as Diclofenac Sodium)
Form Versatile (e.g., Tablet, Gel, Solution for Injection)
Pharmacological class Nonsteroidal Anti-Inflammatory Drug (NSAID)
Common purpose Symptomatic relief from pain and inflammation
Origin Synthetic compound

What Type of Medicine is Difenac? (Identity and Classification)

Difenac is the trade name for a medicine whose core component is the active ingredient Diclofenac, which is formally classified as a Nonsteroidal Anti-Inflammatory Drug (NSAID). This classification identifies it as a powerful synthetic compound that works to relieve pain and reduce inflammation. Diclofenac is a member of the phenylacetic acid chemical group and is typically prepared as a single-ingredient product, most often as Diclofenac Sodium. Diclofenac is included on the List of Essential Medicines, a designation that confirms its relevance for general symptomatic relief in basic healthcare systems. Difenac is frequently positioned as a prescription-only (Rx) option, highlighting its use in situations where strong, medically managed pain control is necessary.


Diclofenac's Composition, Forms, and General Purpose (Substance and Benefit)

The composition of Difenac is centered on Diclofenac Sodium, which is formulated with various pharmaceutical excipients to facilitate delivery via several high-level dosage forms, including oral tablets, topical gels, and solutions for injection. This enables its administration through the oral, topical, rectal, or parenteral routes. The general purpose of Difenac is to provide symptomatic relief by delivering a dual action: strong anti-inflammatory action and an analgesic (pain-relieving) effect. The compound functions by limiting the production of prostaglandins, which are mediators of pain and inflammation. This mechanism helps ease discomfort by controlling the biochemical processes that drive swelling and heightened pain sensitivity, a benefit clinically recognized for providing effective symptomatic relief, such as managing the general discomfort associated with musculoskeletal strain.

Regulatory References

  1. WHO Model Lists of Essential Medicines
  2. WHO Essential Medicines List

What side effects are possible with Difenac?

Possible Side Effects and Safety Information

Difenac (Diclofenac) is a nonsteroidal anti-inflammatory drug (NSAID) whose safety profile, as documented in regulatory sources, is structured by frequency and the body system affected. Adverse reactions are classified using official frequency tiers, ranging from common to very rare.

Frequency and System-Organ Classes

The most common adverse reactions often involve the Gastrointestinal (GI) system (e.g., headache, dizziness, nausea, dyspepsia, abdominal pain) and minor elevations in hepatic enzyme levels. Serious adverse reactions, though rare or very rare, are officially documented across several organ systems.

Serious Adverse Reactions and Key Constraints

Regulatory labeling highlights the risk of serious and potentially fatal gastrointestinal events, including bleeding, ulceration, or perforation, which can occur without warning symptoms at any time during treatment. Furthermore, official safety data indicates an increased risk of serious cardiovascular thrombotic events (such as myocardial infarction and stroke), particularly with higher doses and longer duration of use.

Population-Specific Safety

The official safety profile includes specific constraints. The medication is generally contraindicated in patients with established severe heart failure, severe renal or hepatic impairment, and a history of hypersensitivity to other NSAIDs. Older adults are cited in regulatory documents as having a greater risk for serious, potentially fatal, GI complications. Diclofenac is also contraindicated during the third trimester of pregnancy.

Overdose and Emergency Response

Overdose and When to Seek Help

Overdose symptoms for Diclofenac (Difenac) are documented primarily through gastrointestinal and Central Nervous System (CNS) manifestations. Common clinical presentations listed in official regulatory sources include nausea, vomiting, epigastric pain, and gastrointestinal bleeding. CNS effects that may be documented include lethargy, dizziness, headache, confusion, and tinnitus (ringing in the ears).

While many symptoms are reversible with supportive care, rare but severe outcomes are possible following large ingestions. These life-threatening complications documented in regulatory information include acute renal failure, seizures, and coma. The consequences of acute toxicity are noted to be generally more serious in the elderly, and large ingestions are considered very harmful to children, requiring hospital assessment.

Official regulatory guidance strictly mandates that you seek immediate medical attention or emergency help if an overdose is suspected or has occurred. Contact a poison control center right away to provide details on the amount ingested and receive further instructions. Management relies solely on symptomatic and supportive treatment because no specific antidote is known for Diclofenac overdose.

Therapeutic Uses of Difenac

What Difenac Treats: Main Uses and Benefits

Difenac is used to provide symptomatic relief across several key therapeutic domains marked by pain and inflammation, supporting patients through both persistent and acute symptomatic episodes. The medication is relevant in conditions involving inflammatory processes such as arthritis and acute pain, and can help ease the overall symptom burden.

The medication is commonly used to manage the daily burden of pain and stiffness in chronic conditions like Osteoarthritis and Rheumatoid Arthritis, as well as for short-term assistance with symptoms that follow acute events like injuries, surgical procedures, or the intense cyclical pain of migraine attacks and primary dysmenorrhea.

“Difenac is generally applied across domains where additional symptomatic support is needed to address symptoms that interfere with daily comfort.”

It helps address symptom clusters that may become disruptive during flare-ups, offering supportive therapeutic benefit to assist with maintaining functional stability and ease persistent physical discomfort.

Quick Fact: Symptomatic Support for Pain and Stiffness
Primary Benefit: May assist with maintaining functional stability during periods of heightened symptoms.
Common Use: Used for symptomatic support in chronic joint inflammation and acute pain following trauma.

Regulatory References

  1. NIH MedlinePlus Drug Information

Eligibility and Restrictions for Use

Eligibility Map: Who can and cannot use Difenac — official regulatory information

Difenac (Diclofenac) eligibility is strictly defined by regulatory contraindications and restrictions, primarily related to pre-existing cardiovascular, gastrointestinal, and organ function status.


Category Official Regulatory Statement
Populations for whom use is contraindicated Patients with known hypersensitivity to Diclofenac or other NSAIDs (e.g., aspirin-induced asthma, urticaria) [1.1, 3.2]. Patients undergoing Coronary Artery Bypass Graft (CABG) surgery [1.1]. Patients with established Ischemic Heart Disease, Peripheral Arterial Disease, Cerebrovascular Disease, or Congestive Heart Failure (NYHA Class II–IV) [1.5, 3.3].
Condition-specific contraindications Active gastrointestinal ulceration, bleeding, or perforation [3.1, 3.3]. Severe hepatic failure or severe renal failure (or advanced renal disease) [3.2, 3.4].
Pregnancy and lactation eligibility Contraindicated in the third trimester of pregnancy (at or after 30 weeks gestation) [4.1, 4.2]. Use during the first two trimesters and during lactation is generally not recommended [4.2].
Eligibility-related restrictions Older adults require the lowest effective dose for the shortest duration due to increased risk of serious adverse events [1.1, 3.5]. Children and adolescents (systemic use) are generally not recommended under age 14 or 16 [2.2, 2.4]. Caution is required for patients with mild-to-moderate renal or hepatic impairment [3.1, 3.2].

The regulatory profile classifies groups into these tiers: Contraindicated for those with high established risks (e.g., severe heart failure, active GI bleeding); Restricted/Caution for groups with increased, manageable risks (e.g., older adults, mild organ impairment); and Allowed for all other adults without listed prohibitions [1.1, 1.7, 3.5]. This structure ensures eligibility aligns strictly with documented health risk profiles.

What should I know about interactions with other medicines?

Interactions with other medicines and products for Difenac (Diclofenac) are classified based on official pharmacokinetic (PK) and pharmacodynamic (PD) profiles established in regulatory documents.

Contraindicated Combinations and Co-Toxicity

Difenac is strictly contraindicated in patients with a history of allergic-type reactions, such as asthma or urticaria, following the ingestion of Aspirin or other Nonsteroidal Anti-Inflammatory Drugs (NSAIDs). The co-administration of Difenac with other systemic NSAIDs or COX-2 inhibitors must be avoided due to the documented potential for additive gastrointestinal and cardiovascular adverse effects. The combination with Anticoagulants (like Warfarin), Systemic Corticosteroids, and Selective Serotonin Reuptake Inhibitors (SSRIs) carries an additive pharmacodynamic risk of serious gastrointestinal bleeding or ulceration.

Exposure Modification and Constraints

Difenac may impair the effect of Anti-hypertensives and Diuretics, with co-administration increasing the risk of nephrotoxicity. Concomitant use with the strong CYP2C9 inhibitor Voriconazole is documented to increase Difenac's total systemic exposure (AUC). Furthermore, Difenac can raise the serum concentrations of both Lithium and Digoxin, necessitating regulatory monitoring. Specific oral formulations of Difenac are subject to timing constraints requiring them to be taken on an empty stomach to prevent the documented food-induced reduction in peak plasma concentration (C max). Finally, the co-ingestion of Alcohol (Ethanol) is officially documented to increase the risk of gastrointestinal bleeding.

Mechanism of Action

Molecular Interruption of Prostaglandin Synthesis

The primary mechanism involves competitive inhibition of the Cyclooxygenase ( COX) enzymes, specifically demonstrating functional selectivity for the COX-2 isoform. By blocking the active site, the drug halts the enzymatic conversion of arachidonic acid into pro-inflammatory mediators, such as Prostaglandin E2 ( PGE2 ). This action initiates the entire cascade, resulting in a functional reduction of specific biochemical mediators within affected tissues.

Dampening of Peripheral Nociceptor Excitability

The suppression of PGE2 production directly lowers the excitability of peripheral nociceptors (pain-sensing neurons). These molecular changes limit the chemical sensitization of nerves in the affected tissue, resulting in diminished excitability of afferent neurons and a decreased response to mechanical or chemical stimuli. This action modulates signal propagation within the peripheral nociceptive pathway.

The COX-1 Trade-off and Mechanistic Constraint

The mechanism is constrained by its non-selective action, which includes inhibiting the homeostatic COX-1 enzyme alongside the target COX-2. The inhibition of COX-2 alters the release of pro-inflammatory mediators, but COX-1 inhibition also affects the production of prostaglandins required for normal physiological maintenance, such as those involved in maintaining gastric mucosal integrity. This represents an inherent limit to the mechanism's scope.

Dosage and Administration Information

Administration Guidelines

Difenac is administered according to a core principle: using the lowest effective dose for the shortest duration required to manage symptoms. The medicine is available via multiple routes, including oral (tablets, capsules, solution), topical (gel, solution, patch), rectal, and parenteral (injection) administration. Different oral formulations are not considered bioequivalent and should not be used interchangeably.


Dosing Patterns and Frequency

Standard oral regimens for chronic conditions, such as arthritis, typically range from 100 mg to 150 mg total per day, often administered in divided doses (e.g., twice or three times daily) or as a single 100 mg dose in an extended-release form. For acute situations, like a migraine, a single 50 mg dose of the oral powder for solution is utilized. Topical gel is prescribed to be applied four times daily (q.i.d.), with the total systemic daily amount strictly limited. Parenteral administration (IM or IV) is generally restricted to a short course, often no more than two consecutive days.


Preparation and Use Conditions

The administration of Difenac is highly form-dependent. Extended- or delayed-release tablets must be swallowed whole and should never be split, crushed, or chewed, as this compromises the drug’s controlled delivery system. Conversely, the oral powder for acute pain must be mixed with a small volume of water and consumed on an empty stomach to ensure rapid absorption. General clinical practice suggests that older adults or individuals with low body weight should begin treatment using the lowest available dose.

Recent Clinical Evidence

Research Evidence / Overview of Studies


Research on Measured Outcomes

Research has investigated the effects of Difenac in relation to a specific inflammatory condition. These studies primarily focused on objective clinical endpoints and patient-reported measures.

  • Studies examined data related to changes in symptoms among participants receiving the drug compared to placebo groups.
  • Researchers documented whether the severity and duration of flare-ups showed differences between the treatment group and controls.
  • Some research has examined the time to potential symptom reduction in open-label trials.
  • Studies tracked changes in the level of disease activity over the long-term observation period in some cohorts.

Effects and Experiences Profile

The effects and experiences of Difenac in adult populations were evaluated in clinical trials. This assessment helps determine the general response of the study populations to the drug.

  • Common Adverse Events: The studies measured the frequency of reported adverse events.
  • Serious Events: Researchers tracked the incidence of serious adverse events in all phases of the trials.
  • Studies involving participants with a history of concurrent serious illnesses were not included in the core clinical review.

Combination Research

Difenac was studied in combination with another approved treatment in several Phase III trials, specifically exploring administration in patients who had an inadequate response to monotherapy.

  • Research explored whether the combination resulted in different quality of life scores compared with other treatments studied in the same trial design.
  • One meta-analysis reviewed trial data to establish the frequency of treatment discontinuation across various groups.

Frequently Asked Questions (FAQ)

Common questions about Difenac (FAQ)


Q: Does Difenac only treat pain, or does it also help with swelling?

Difenac is officially described as having a dual action. The medicine provides both an analgesic (pain-relieving) effect and a strong anti-inflammatory action. This anti-inflammatory action may contribute to the reduction of swelling associated with various conditions.


Q: Is it true that Difenac can affect the liver?

Official safety information indicates that minor elevations in liver enzyme levels are a common adverse reaction. While severe liver issues are rare, they are a documented risk. For this reason, the medicine is contraindicated in patients with severe hepatic failure.


Q: Does Difenac have a risk of causing stomach problems?

Yes, according to official safety information, the most common adverse reactions often involve the gastrointestinal system (GI), such as abdominal discomfort. Regulatory documents also highlight a risk of serious GI events, which can include bleeding or ulceration.


Q: Can Difenac interfere with birth control pills?

Regulatory patient information generally indicates that Difenac will not directly interfere with the function of hormonal contraceptives, such as birth control pills. However, if the medicine causes severe vomiting or diarrhea, this could potentially affect the effectiveness of an oral contraceptive.


Q: What are the signs of a serious allergic reaction to Difenac?

Serious allergic reactions, which can occur without warning, may include symptoms like severe skin reactions (such as widespread rash or blistering) or signs of anaphylaxis (e.g., difficulty breathing). Regulatory documents note that patients are advised to discontinue the medicine at the first sign of a skin rash or other immediate hypersensitivity.


Q: Is there a link between Difenac and heart health concerns?

Official safety data highlights a link between Difenac and an increased risk of serious cardiovascular thrombotic events, such as heart attack or stroke. This risk is primarily associated with higher doses and longer duration of use. The medicine is contraindicated in individuals with certain established heart conditions.


Q: What research themes are commonly highlighted in official reviews of Difenac?

Official reviews of Difenac research tend to focus on three main themes. These include measured clinical outcomes (such as changes in disease activity), the overall effects and experiences profile (including documentation of adverse events), and studies of the drug when used in combination with other therapies.


Q: Can Difenac be used if a person has a history of asthma?

Official regulatory guidance states that Difenac is strictly contraindicated if a person has a history of allergic-type reactions, such as asthma or hives (urticaria), following the ingestion of aspirin or other nonsteroidal anti-inflammatory drugs (NSAIDs).


Q: How long does it typically take to feel the effect of Difenac after taking it?

The time required to feel the intended effect depends on the specific form of the medicine. Oral tablets or capsules typically begin working within 20 to 30 minutes. Topical gels, patches, or suppositories may require more time to provide symptomatic relief.


Q: Can Difenac be taken on an empty stomach?

Official guidance on food intake is specific to the formulation. For example, the oral powder for acute pain is indicated to be consumed on an empty stomach. Conversely, some other oral tablets are sometimes recommended to be taken with food or milk to help minimize the potential for stomach irritation.


Q: What happens if a dose of Difenac is missed?

Regulatory patient information often describes a procedure for missed doses: the dose may be taken as soon as it is remembered, unless the next scheduled dose is approaching. The instructions generally indicate that the missed dose should be skipped in that situation, and that a double dose should be avoided.


Q: Are there any specific foods or drinks to avoid while using Difenac?

Regulatory guidance specifically warns that the co-ingestion of alcohol is documented to increase the risk of serious gastrointestinal bleeding associated with Difenac use. There are no other common foods or drinks that are strictly prohibited in the official regulatory documents.


Q: Is Difenac a type of steroid medicine?

No, Difenac is not a steroid medicine. It is formally classified as a Nonsteroidal Anti-Inflammatory Drug (NSAID). This classification identifies it as a synthetic compound used to relieve pain and reduce inflammation.


Q: Can Difenac be used for managing chronic pain?

Difenac is officially used in regimens for chronic conditions, such as arthritis, which often involve managing persistent pain. However, regulatory guidance consistently emphasizes the principle of using the lowest effective dose for the shortest duration required to manage symptoms.


Q: What kind of studies have been done on the long-term use of Difenac?

Clinical research has included tracking changes in disease activity over long-term observation periods in some study populations. Furthermore, official safety data highlights that the risk of serious adverse events, particularly those affecting the heart and kidneys, are associated with a longer duration of use.


Q: Can Difenac make you feel dizzy or drowsy?

Yes, official regulatory documents list dizziness as a common adverse reaction that may occur. Drowsiness has also been reported as a potential side effect in some official product information.


Q: Is it possible to take Difenac for minor headaches?

The official use conditions for Difenac include treatment for acute situations, such as migraine, which is a specific type of headache. Specific regulatory labeling for general or minor headaches is not uniformly available in all official product information.


Q: How long does Difenac stay in your system?

The effects of oral Difenac typically wear off after about 15 hours, though this can vary between individuals and formulations. Pharmacokinetic data indicates the elimination half-life is approximately 1.2 to 2 hours.


Q: Is Difenac available without a prescription in some countries?

While many oral forms are generally positioned as prescription-only (Rx), certain topical gel formulations have been approved by regulatory bodies for non-prescription (over-the-counter) use. This means its status depends entirely on the specific country and dosage form.


Q: What is the difference between Difenac tablets and the topical gel version?

The key difference is their application and effect. Oral tablets provide a systemic (whole-body) effect for various inflammatory conditions. In contrast, the topical gel provides a more localized effect and is approved for conditions like osteoarthritis of the hands and knees.


Q: Does Difenac cause fluid retention or swelling in the ankles?

Regulatory documents note that Difenac may cause fluid retention and swelling (edema) as a potential effect. This is a factor considered in the official warnings and precautions, and caution is noted for patients with heart failure.


Q: Are there any known interactions between Difenac and alcohol?

Yes, regulatory guidance documents indicate a known interaction. The co-ingestion of alcohol is officially documented to increase the risk of serious gastrointestinal bleeding associated with Difenac use.


Q: What should a person do if they notice unusual bruising while taking Difenac?

Since Difenac is associated with risks of bleeding and hematologic issues, official patient counseling information advises that signs of unusual or unexplained bleeding or bruising are noted and should be discussed with a healthcare provider.


Q: Can Difenac affect sleep quality?

Clinical studies have explored the effect of Difenac on sleep quality, particularly when pain disturbs sleep. Research has documented that the medicine has been shown to help improve objective and subjective measures of sleep quality by relieving nighttime discomfort.


Q: Can Difenac be used for post-surgery discomfort?

Yes, the official use conditions for Difenac include the management of mild to moderate acute pain. This scope of use includes managing both postoperative (after surgery) and post-traumatic discomfort.


Q: Is it required to taper off Difenac, or can usage be stopped suddenly?

Regulatory information on Difenac does not include tapering instructions. The effects of the medicine will wear off over a short period after the last dose is taken, unlike some other drug classes.


Q: Does Difenac interact with herbal supplements like St. John's Wort?

Official drug information highlights that Difenac is metabolized by specific CYP enzymes in the body. Certain herbal supplements, such as St. John's Wort, are known to affect these enzymes, which could potentially alter the body's exposure to Difenac.


Q: Can Difenac cause sensitivity to sunlight?

Some regulatory patient information notes the potential for photosensitivity (increased sensitivity to sunlight) as an adverse reaction. Precautions against exposure to natural and artificial sunlight are generally noted in the guidance.


Q: What is the purpose of the coating on some Difenac tablets?

The coating on certain tablets is a feature of a controlled-delivery system for delayed- or extended-release formulations. Its purpose is to ensure the medicine is released slowly over time or delayed until it reaches the intestine, rather than the stomach.


Q: Is Difenac commonly used in other parts of the world?

Yes, the active ingredient in Difenac, Diclofenac, is widely recognized globally. It is included on the World Health Organization’s (WHO) List of Essential Medicines, which confirms its importance for general symptomatic relief in basic healthcare systems worldwide.


Q: Does Difenac have any effect on blood sugar levels?

Regulatory data does not typically list Difenac as having a common, direct effect on blood sugar levels in the patient information. However, official labeling may contain specific warnings or precautions for use in patients with pre-existing diabetes.


Q: Can Difenac be safely stored in the bathroom medicine cabinet?

Regulatory guidance advises against storing Difenac in the bathroom. The medicine must be protected from moisture and light. Bathrooms are typically not suitable storage locations due to fluctuating temperatures and high humidity levels.


Q: Is Difenac mentioned in clinical guidelines for migraine treatment?

Yes, a specific dose and formulation of Difenac is officially utilized and regulated for the treatment of acute situations, such as migraine. This utilization is often reflected in current clinical guidance for headache management.


Q: Can Difenac affect mood or cause anxiety?

Adverse effects documented in regulatory sources can include effects on the central nervous system and psychiatric problems. Among the reported effects, anxiety is one of the reactions noted in official product information.


Q: Is Difenac known to be safe during short-term use?

The core regulatory principle for Difenac use is to use the drug for the shortest duration possible to manage symptoms. This is because the risk of serious adverse events, particularly cardiovascular and gastrointestinal issues, is primarily associated with a longer duration of use.

How should Difenac be stored and disposed of?

Difenac (diclofenac) requires adherence to specific conditions for storage and disposal, as defined in official regulatory documents to maintain stability and prevent misuse.


Storage Requirements

Temperature and Protection: Diclofenac oral tablets must be stored below 30°C (86°F) and protected from both moisture and light. Liquid formulations, such as topical solutions, are strictly labeled with the instruction: Do not freeze.

Packaging and Safety: The medicine must be kept in a tight, light-resistant container and stored in a secure location that ensures it is out of the sight and reach of children.

Disposal Instructions

Unused or expired Difenac must be discarded strictly in accordance with local regulations. Official guidance states that the product must not be thrown into wastewater or household waste; instead, it should be managed as pharmaceutical waste, typically by returning it to a collection point or pharmacy.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Difenac found in:

A-Z Index: